APA

Rebbeck T. R., Friebel T., Wagner T., Lynch H. T., Garber J. E., Daly M. B., Isaacs C., Olopade O. I., Neuhausen S. L., van 't Veer L., Eeles R., Evans D. G., Tomlinson G., Matloff E., Narod S. A., Eisen A., Domchek S., Armstrong K. & Weber B. L. (20051209). Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Rebbeck Timothy R, Friebel Tara, Wagner Theresa, Lynch Henry T, Garber Judy E, Daly Mary B, Isaacs Claudine, Olopade Olufunmilayo I, Neuhausen Susan L, van 't Veer Laura, Eeles Rosalind, Evans D Gareth, Tomlinson Gail, Matloff Ellen, Narod Steven A, Eisen Andrea, Domchek Susan, Armstrong Katrina and Weber Barbara L. 20051209. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Rebbeck T. R., Friebel T., Wagner T., Lynch H. T., Garber J. E., Daly M. B., Isaacs C., Olopade O. I., Neuhausen S. L., van 't Veer L., Eeles R., Evans D. G., Tomlinson G., Matloff E., Narod S. A., Eisen A., Domchek S., Armstrong K. and Weber B. L. (20051209). Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Rebbeck Timothy R, Friebel Tara, Wagner Theresa, Lynch Henry T, Garber Judy E, Daly Mary B, Isaacs Claudine, Olopade Olufunmilayo I, Neuhausen Susan L, van 't Veer Laura, Eeles Rosalind, Evans D Gareth, Tomlinson Gail, Matloff Ellen, Narod Steven A, Eisen Andrea, Domchek Susan, Armstrong Katrina and Weber Barbara L. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20051209.